AI Science Tracker
EN

Learned cell-death signature associates with lung cancer survival

Shandong University; Shandong First Medical University · 28 Jun 2023 · medicine

Discovery

Learned cell-death signature associates with lung cancer survival

Source check: Source checked. Not independent scientific confirmation.

Finding: LASSO and random-forest screening identified a five-gene programmed-cell-death index in 500 lung-adenocarcinoma cases. Higher scores were associated with poorer overall survival, with similar associations in three public external cohorts. Separate tissue staining examined selected model genes. Drug sensitivity and immunotherapy response were computational estimates, rather than demonstrated treatment effects or clinical benefit.

Technology: LASSO; random forest; consensus clustering

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Penalized regression and random-forest selection prioritize genes for an outcome-linked expression signature, enabling survival-association analyses.
Test and result
Retrospective survival associations of a learned five-gene signature in TCGA and three additional GEO cohorts; selected protein-expression checks in tissue.
Limitation / still unknown
Prospective clinical utility, treatment-response prediction and causal roles of the signature remain unestablished; cohort-specific thresholds and retrospective selection limit interpretation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11797341/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.